Hosted on MSN14d
CDC investigating hospitalizations of five people who recently received chikungunya vaccineIn a notice posted Tuesday on a vaccine information page for health-care providers, the CDC said that the people, all 65 and ...
NEW YORK CITY, NY / ACCESS Newswire / March 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older The European Commission (EC) will now review ...
IXCHIQ is a single-dose, live-attenuated vaccine indicated for active immunization against the chikungunya virus, and represents the first (and currently only) chikungunya vaccine. According to ...
Valneva has met its revenue growth target for 2024, fending off slower-than-expected sales for the chikungunya vaccine Ixchiq. The French vaccine specialist posted total revenues of €169.6m ($ ...
“Let’s not draw any conclusions yet. That’s why they’re doing the investigation.” The IXCHIQ vaccine, administered as a single-dose shot into the muscle, contains a live, weakened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback